Yeast expressing hepatitis B virus surface antigen determinants on its surface: Implications for a possible oral vaccine

Vaccine

Volumn 14, Issue 5, 1996, Pages 383-388

  Schreuder, M P ^a   Deen, C ^b   Boersma, W J A ^b   Pouwels, P H ^b   Klis, F M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b TNO   (Netherlands)

Author keywords

Cell wall; HBsAg; Immobilized protein; Saccharomyces cerevisiae; Surface presentation

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HYBRID PROTEIN; RECOMBINANT HEPATITIS B VACCINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HEPATITIS B; HEPATITIS B VIRUS; INTRAPERITONEAL DRUG ADMINISTRATION; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION; YEAST;

EID: 0029878805     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(95)00206-G     Document Type: Article

References (33)

1. Czerkinsky, C., Svennerholm, A. and Holmgren, J. Induction and assessment of immunity at enteromucosal surfaces in humans: implications for vaccine development. Clin. Infect. Dis. 1993, 16, S106-S116
2. Walker, R.I. New strategies for using mucosal vaccination to achieve more effective immunisation. Vaccine 1994, 12, 387-400
3. Service, R.F. Triggering the first line of defence. Science 1994, 265, 1994 1522-1524
4. Schellenberg, D., Bonington, A., Champion, C.M., Lancaster, R., Webb, S. and Main, J. Treatment of Clostridium difficile diarrhoea with brewer's yeast. Lancet 1994, 343, 171-172
5. Fattal-German, M. and Bizzini, B. Assessment of the anti-viral effect of a short-term oral treatment of mice with live Saccharomyces cerevisiae cells. Dev. Biol. Stand. 1992, 77, 115-120
6. McFarland, L.V. and Bernasconi, P. Saccharomyces boulardii: a review of an innovative biotherapeutic agent. Microbiol. Ecol. Hlth Dis. 1993, 6, 157-171
7. Corthier, G., Lucas, R., Jouvert, S. and Castex, F. Effect of oral Saccharomyces boulardii treatment on the activity of Clostridium difficile toxins in the mouse digestive tract. Toxicon 1992, 30, 1583-1589
8. Berg, R., Bernasconi, P., Fowler, D. and Gautreaux, M. Inhibition of Candida albicans translocation from the gastrointestinal tract of mice by oral administration of Saccaromyces boulardii. Infect. Dis. 1993, 168, 1314-1318
9. Schreuder, M.P., Brekelmans, S., van den Ende, H. and Klis, F.M. Targeting of a heterologous protein to the cell wall of Saccharomyces cerevisiae. Yeast 1993, 9, 399-409
10. Tsai, P.K., Frevert, J. and Ballou, C.E. Carbohydrate structure of Saccharomyces cerevisiae mnn9 mannoprotein. J. Biol. Chem. 1984, 259, 3805-3811
11. De Nobel, J.G., Klis, F.M., Priem, J., Munnik, T. and van den Ende, H. The glucanase-soluble mannoproteins limit cell wall porosity in Saccharomyces cerevisiae. Yeast 1990, 6, 491-499
12. Maniatis, T, Fritsch, E.F., Sambrook, J. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1992
13. Murray, K., Bruce, S.A., Hinnen, A. et al. Hepatitis B Virus antigens made in microbial cells immunise against viral infection. EMBO J. 1984, 3, 645-650
14. Gietz, R.D. and Sugino, A. New yeast-Escherichia coli shuttle vectors constructed with in vitro mutagenized yeast genes lacking six-base pair restriction sites. Gene 1988, 74, 527-534
15. Lopes, T.S., Klootwijk, J., Veenstra, A. et al. High-copy-number integration into the ribosomal DNA of Saccharomyces cerevisiae: a new vector for high level expression. Gene 1989, 79, 199-206
16. Gietz, D., St. Jean, A., Woods, R.A. and Schiestle, R.H. Improved method for high efficiency transformation of intact yeast cells. Nucl. Acids Res. 1992, 20, 1425
17. Klasen, E.A., Rigutti, A., Bos, A. and Bernini, L.F. Development for a screening system for detection of somatic mutations. II. The use of peptides and insoluble protein fragments in a non-competitive solid phase enzyme immunoassay. J. Immunol. Meth. 1983, 59, 281-287
18. Boersma, W.J.A., Haaijman, J.J. and Claassen, E. Immunohistochemistry II (ed. Cuello, A.C.). J. Wiley and Sons, New York, 1993, pp. 1-77.
19. Stirk, H.J., Thornton, J.M. and Howard, C.R. A topological model for Hepatitis B surface antigen. Intervirology 1992, 33, 148-158
20. Kuroki, K., Russnak, R. and Ganem, D. Novel N-terminal amino add sequence required for the retention of a Hepatitis B Virus glycoprotein in the endoplasmatic reticulum. Mol. Cell. Biol. 1989, 9, 4459-4466
21. Neurath, A.R. and Kent, S.B.H. The pre-S region of hepadnavirus envelope proteins. Adv. Virus Res. 1988, 34, 65-142
22. Pontisso, P., Ruvoletto, M.G., Tiribelli, C., Gerlich, W.H., Ruol, A. and Alberti, A. The preS1 domain of Hepatitis B Virus and IgA cross-react in their binding to the hepatocyte surface. J. Gen. Virol. 1992, 73, 2041-2045
23. Neurath, A.R., Jameson, B.A. and Huima, T. Hepatitis B Virus proteins eliciting protective immunity. Microbiol. Sci. 1987, 2, 45-51
24. Gerlich, W.H., Heermann, K.H. and Xuanyong, L. Functions of Hepatitis B surface proteins. Arch. Virol. 1992, 4, 129-132
25. Waters, J.A., Brown, S.E., Steward, M.W., Howard, C.R. and Thomas, H.C. Analysis of the antigenic epitopes of the Hepatitis B surface antigen involved in the induction of a protective antibody response. Virus Res. 1991, 22, 1-12
26. Machida, A., Okamoto, R., Tsuda, R., Tanaka, T., Domoto, K. and Mishiro, S. Anti-preS2 neutralizes the hepatitis B virus variant with a vaccine-escape mutation at the amino acid position 126 or 145 within the S gene. Int. Hepatol. Commun. 1994, 2, 186-189
27. Neurath, A.R., Kent, S.B.R., Parker, K. et al. Antibodies to a synthetic peptide from the preS2 120-145 region of the Hepatitis B Virus envelope are virus-neutralizing. Vaccine 1986, 4, 35-37
28. Manivel, V., Ramesh, R., Panda, S.K. and Rao, K.V.S. A synthetic peptide spontaneously self-assembles to reconstruct a group-specific, conformational determinant of the Hepatitis B Virus surface antigen. J. Immunol. 1992, 148, 4006-4011
29. Tiollais, P. and Buendia, M.A. Hepatitis B Virus. Sci. Am. 1991, 264 (4), 48-54
30. Kumar, V., Bansal, V.J., Rao, K.V.S. and Jameel, S. Hepatitis B Virus envelope epitopes: gene assembly and expression in Escherichia coli of an immunologically reactive novel multiple-epitope polypeptide 1 (MEP-1). Gene 1992, 110, 137-144
31. Ballou, C.E. Isolation, characterization and properties of Saccharomyces cerevisiae mnn mutants with non-conditional protein glycosylation defects. Meth. Enzymol. 1990, 185, 440-470
32. Teunissen, A.W.R.H., van den Berg, J.A. and Steensma, H.Y. Physical localisation of the flocculation gene FLO1 on chromosome 1 of Saccharomyces cerevisiae. Yeast 1993, 9, 1-10
33. Roy, A., Lu, C.R., Marykwas, D., Lipke, P. and Kurjan, J. The AGA1 product is involved in cell surface attachment of the Saccharomyces cerevisiae cell adhesion glycoprotein α-agglutinin. Mol. Cell. Biol. 1991, 11, 4196-4206